Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. - Wikidata - wikimedia - TriplyDB

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

http://www.wikidata.org/entity/Q33896961

about

BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets Mutator pathways unleashed by epigenetic silencing in human cancer Epimutation and cancer: a new carcinogenic mechanism of Lynch syndrome (Review)The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells BRCAness: finding the Achilles heel in ovarian cancer High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3 The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer Molecular tumor profiling: translating genomic insights into clinical advances Characteristic promoter hypermethylation signatures in male germ cell tumors Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome The p53 pathway in breast cancer Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer Induced pluripotent stem cell technology for dissecting the cancer epigenome Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors BRCA1, a 'complex' protein involved in the maintenance of genomic stability Epigenetics in breast cancer: what's new?Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers Breast cancer epigenetics: from DNA methylation to microRNAs Integrated genomic analyses of ovarian carcinoma Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine Epigenetics in Cancer: A Hematological Perspective Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood Lung cancer epigenetics: emerging biomarkers Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers Methylation matters DNA damage response genes and the development of cancer metastasis BRCA1 and Oxidative Stress A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis

P2860

Q21195223-A5A354D6-6F56-495B-9F10-6F2EFC769762 Q21245727-446CDA64-56EF-4788-9196-0175D32B7E54 Q22242850-32467528-3A03-415A-9A83-D158D24B8615 Q22255392-334CF95D-1AAB-43E7-9D6B-AD50863F4010 Q24291361-C346C6B2-7B64-4CA0-861C-0A8D3F00D612 Q24291505-8DC3CA84-03E5-4483-B205-4F5AC7EDB945 Q24630872-5E5A3063-7C5E-4811-AAE3-9845A9F2CEC4 Q24648804-9D01568A-D93E-4627-8AE1-3D9E4803F567 Q24683906-CD54D497-F757-4A3A-8DA3-62E5953E99DF Q24791520-02CF45C3-3F3B-48B6-AC00-AC5A189EB72A Q24797250-7470E1B7-2FE3-4603-B49B-45E9C0DEA5A5 Q24799928-78E8C6E5-5D6F-4ED9-AE54-90F3E6005F70 Q24800480-520BFDF4-C536-45CC-BD7E-CE0B5572C7A3 Q24802349-CD15BE94-0576-44FB-A81C-F248ED191CF4 Q26747279-0F0D236B-B57B-4E65-947E-F294DA2991F2 Q26778761-C67D98BD-75E2-47A6-A1C2-4AFE4BCE6E2C Q26783551-A724547F-9EEF-4995-9DA5-1F70C975E02A Q26801711-318F9DE1-495F-499A-9459-EB9220D902CD Q26851813-2827B82F-B898-4BB0-84B0-CF3401D863A8 Q26852274-3FCCC566-D615-402B-9129-497CE5F5F6BF Q26853262-24E26704-2221-4A96-A6E1-E30E6F0CB057 Q26991779-4ADF1EA4-81B0-4362-A31B-84DE3A91F055 Q27006938-DA8BE55A-A9F2-4997-82D5-F34C9A1F9265 Q27694164-3AD70D18-1221-481C-AC5D-1E1273C5F1F0 Q27860518-9A296B50-600B-437A-8BE5-52180CE01B43 Q28071541-ED0D70E3-88B4-4EC2-843B-75F9776FBA6C Q28072204-16395C5C-AFDB-4944-94C0-1DB87C7C63CA Q28077082-398610EA-D3BA-4A56-BD8F-CC86120F7873 Q28188554-10133AD6-9E1D-4635-ACD5-181F92101500 Q28215348-65D21225-22EE-4C4A-836D-18F59151950B Q28242111-17C3113B-6921-4BED-A3AE-97436396323A Q28255059-A680143B-9EDC-4FA8-B3F9-D621A224BD63 Q28285049-D90A3FFA-49CF-4E93-927C-3D6A39401F90 Q28286269-6E27C3E7-0484-4152-BDBC-7E70855F0511 Q28343483-D3F0537D-3CA6-430B-B964-D8FF2D12A363 Q28364163-613270B8-EECC-41C1-BC82-B9DF832FD370 Q28388312-2D5CCD1F-9D0E-4B5E-B56C-B85073F757F7 Q28388921-06A19CFC-CF25-4572-8AED-D6652E18FD7F Q28469084-211E61C3-5023-4AE5-959B-184D7E838CE9 Q28472991-20E15043-2B95-4B59-969B-D132A4E76757

P2860

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

http://www.wikidata.org/entity/Q33896961

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

@ast

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

@en

type

label

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

@ast

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

@en

prefLabel

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

@ast

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

@en

P1433

Q33896961-322BDD49-9472-4F66-8A8C-482CD6077521

P1476

Q33896961-5068A4DA-985C-4463-A9E1-97B326C203DE

P2093

Q33896961-1D3CD9E5-6C8C-401E-9446-2957F108AE1E

Q33896961-2A53A0DF-160A-41C5-9912-B427807ECEC8

Q33896961-3D550844-2172-416A-8842-F2F5451458AF

Q33896961-48A95976-E881-4233-9EE1-8FE733BF8EE0

Q33896961-516C0AF9-49A1-4594-A89B-B49D24B1DAFE

Q33896961-5384B750-A343-4A40-8865-50F7D24BF619

Q33896961-60A29F3A-49A9-4DF6-8FD9-559433D4BBAC

Q33896961-7A7A3E51-B89C-4C3E-9F4D-1BA2F08F67FC

Q33896961-97B9A10C-FF2A-4983-A552-F4DC0B39CA64

Q33896961-9D5F1423-D13A-4DEC-B4C3-0B667F0B0477

P304

Q33896961-8CE524C0-4105-4DCB-8190-21BB3714B4CC

P31

Q33896961-C5EE801E-9536-4BE3-9B51-0A5CB9AD6529

P356

Q33896961-30BE3C68-101A-4C14-A506-728BB68BA3F5

P407

Q33896961-48098BB3-7B63-43DA-A3E4-A8769D5111DA

P433

Q33896961-F6FCC0CD-86CA-4A7E-A813-84BAD0E20BD0

P478

Q33896961-EE5F4A0B-306C-4F5A-903C-C0450DBD67AB

P50

Q33896961-1C91F8FB-644A-4CD3-AAC2-973269D20A0B

P577

Q33896961-D46F53BF-02E2-4CC8-8C2F-76A8FF2D07E2

P5875

Q33896961-F07CC473-AF0E-48CE-9007-3F676C1ED928

P698

Q33896961-FB29F8C8-FC9B-47D5-BCDD-65ABDBB74684

P356

P1433

Journal of the National Cancer Institute

P1476

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

@en

P2093

Baylin SB

http://www.w3.org/2001/XMLSchema#string

Bonilla F

http://www.w3.org/2001/XMLSchema#string

Bussaglia E

http://www.w3.org/2001/XMLSchema#string

Dominguez G

http://www.w3.org/2001/XMLSchema#string

Gabrielson E

http://www.w3.org/2001/XMLSchema#string

Harkes IC

http://www.w3.org/2001/XMLSchema#string

Herman JG

http://www.w3.org/2001/XMLSchema#string

Lerma E

http://www.w3.org/2001/XMLSchema#string

Matias-Guiu X

http://www.w3.org/2001/XMLSchema#string

Prat J

http://www.w3.org/2001/XMLSchema#string

P304

564-569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/92.7.564

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275298798

http://www.w3.org/2001/XMLSchema#string

P698

10749912

http://www.w3.org/2001/XMLSchema#string